Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- RAMBAM Health centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female or men
- Diagnosed with Parkinson's disease (according to Brain Bank UK criteria)
- Non-demented
- Age: ≥ 30 years
- Gait disturbances
- Patients who are able to perform questionnaires and physical tests (including computerized tests)
- Gave informed consent for participation in the study
Exclusion Criteria:
- Unstable (less than 1 month) use of concomitant medications that might affect the balance system
- Change of PD medications during the past month
- Any medical condition or disorder that could produce gait or balance disturbances unless well controlled for at least 3 months
- Blindness
- Currently taking part in a clinical trial or within 30 days prior to screening
- Any known condition which in the opinion of the investigator may impair gait or balance and/or limits the successful trial completion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: SpotOn Balance
SpotOn Balance Glasses
|
SpotOn Balance Glasses comprising of personalized visual stimuli placed on the glasses's lenses
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unified Parkinson's disease rating scale
Time Frame: 3 weeks
|
A comprehensive 50 question clinical rating scale for the assessment of both motor and non-motor symptoms associated with Parkinson's.
The total cumulative score will range from 0 (no disability) to 199 (total disability).
|
3 weeks
|
|
TIMED UP AND GO (TUG)
Time Frame: 3 weeks
|
The TUG test is a physical performance measure in which the ability to rise up from a seated chair position, walk 3m, turn, walk back, and sit down is timed.
|
3 weeks
|
|
Berg Balance Scale (BBS)
Time Frame: 3 weeks
|
The BBS is a widely used clinical test of a person's static and dynamic balance abilities.
t is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.A score of 56 indicates functional balance.
|
3 weeks
|
|
Non-Motor Symptoms Scale (NMSS)
Time Frame: 3 weeks
|
The non-motor symptoms questionnaire is a 30-point, patient-based questionnaire used to determine the non-motor symptoms experienced by the patient during the past month.Responses quantify symptoms according severity (using a scale of 0-3) and frequency (using a scale of 0-4).
Higher scores represent more severe and more frequent symptoms.
|
3 weeks
|
|
39-item Parkinson's Disease Questionnaire (PDQ-39)
Time Frame: 3 weeks
|
This questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living.
It is scored on a scale of 0-100, with lower scores indicating better health and high scores more severe symptoms.
|
3 weeks
|
|
Freeze of gait (FOG) Questionnaire
Time Frame: 3 weeks
|
Consists of 16 items assessing freeze of gait.
Total score ranges from 0 to 24, higher score corresponds to more severe FOG.
|
3 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ilana Shlezinger, MD, Rambam Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SpotOn_03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.